Responsive image

Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics to Benefit

Argenx SE (NASDAQ:ARGX) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED). The decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the trials for futility following its review […]
Responsive image

What’s Going On With ExxonMobil Stock Today?

Shares of Exxon Mobil Corporation (NASDAQ:XOM) are trading higher Tuesday after the oil and gas company highlighted a stronger outlook for earnings and cash flow in its corporate plan. Exxon Mobil shares are trending higher. What’s driving XOM shares up? What To Know: ExxonMobil updated its corporate plan through 2030, forecasting increases of $5 billion in […]
Responsive image

What’s Going on with Palantir Technologies Stock Tuesday?

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading marginally higher on Tuesday, hovering around $182, as the company rides a wave of strategic expansions that has fueled a 7% rally over the past five sessions. Here’s what investors need to know. Palantir stock is showing positive momentum. What should traders watch with PLTR? What To Know: […]
Responsive image

Physical Metal Shortage Setting The Calendar For Silver Squeeze In 2026

The silver market might be setting up for a structural shock in 2026. A tightening physical supply colliding with a leveraged futures and derivatives market is a frightening prospect. The latest episode of The Sirius Report cast a spotlight on the setup, framing the ongoing dynamics on COMEX and the London Bullion Market Association as […]
Responsive image

Capricor Therapeutics Duchenne Treatment Shows Strong Heart and Muscle Results in Trial

Capricor Therapeutics Inc. (NASDAQ:CAPR) stock is rallying on Wednesday. The company shared much-awaited topline results from its pivotal Phase 3 HOPE-3 trial evaluating Deramiocel, the company’s investigational cell therapy for Duchenne muscular dystrophy (DMD). CAPR shares are climbing with conviction. Get the latest updates here. Duchenne muscular dystrophy (DMD) is a severe, inherited genetic disorder […]
Responsive image

Walmart, Leidos, Zoom and a Utility Stock on CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Capital Wealth Planning CEO Kevin Simpson picked Walmart Inc. (NYSE:WMT), praising its recent earnings report. E-commerce is expanding, membership model is growing, and the company’s management issued a strong forward guidance, he added. Walmart, on Nov. 20, reported better-than-expected third-quarter financial results and raised its fiscal year 2026 revenue […]
Responsive image

Alphabet, Welltower And A Consumer Cyclical Stock On CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” on Thursday, Bryn Talkington, managing partner of Requisite Capital Management, named Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) as her final trade. Shares of Magnificent Seven stock Alphabet have soared to new all-time highs in recent days and posted an impressive gain of 54% year-to-date in 2025. Investors in the tech giant […]

    Newsletter

    GameStop Is Back — What’s Fueling the 2025 Comeback?

    June 18, 2025

    Introduction GameStop Corp. (NYSE: GME) is once again making headlines in 2025, not just as a meme stock phenomenon, but as a company mounting a potentially serious turnaround. After years of volatility and skepticism, the stock has rallied more than 70% year-to-date—fueled by a new business strategy, improved financial performance, and a renewed wave of […]
    Read More